Sarah A. Bird

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma.

Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma.

Journal: Nature
Published: August 19, 2025

EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.

EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.

Journal: Haematologica
Published: April 12, 2025

Outbreak of Pseudomonas aeruginosa perichondritis associated with ear piercings and a contaminated water system.

Outbreak of Pseudomonas aeruginosa perichondritis associated with ear piercings and a contaminated water system.

Journal: Epidemiology and infection
Published: January 10, 2025

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma.

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma.

Journal: Blood
Published: July 02, 2024

A large cryptosporidiosis outbreak associated with an animal contact event in England: a retrospective cohort study, 2023.

A large cryptosporidiosis outbreak associated with an animal contact event in England: a retrospective cohort study, 2023.

Journal: Epidemiology and infection
Published: May 27, 2024

Predictors of anxiety and depression in operating room nurses during the COVID-19 pandemic: A multi-center cross-sectional study.

Predictors of anxiety and depression in operating room nurses during the COVID-19 pandemic: A multi-center cross-sectional study.

Journal: Work (Reading, Mass.)
Published: January 08, 2024

Corrigendum to "Toe amputation: A predictor of future limb loss?" [J. Diabetes Complicat. 26(3) (May-Jun 2012) 251-4].

Corrigendum to "Toe amputation: A predictor of future limb loss?" [J. Diabetes Complicat. 26(3) (May-Jun 2012) 251-4].

Journal: Journal of diabetes and its complications
Published: July 08, 2023

IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact.

IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact.

Journal: Blood
Published: January 06, 2023

Lenalidomide and risk of second primary malignancy-is disease context key?

Lenalidomide and risk of second primary malignancy-is disease context key?

Journal: The Lancet. Haematology
Published: October 07, 2022

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.

Journal: The Lancet. Haematology
Published: March 26, 2021

Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience.

Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience.

Journal: Leukemia & lymphoma
Published: December 28, 2020

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial.

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial.

Journal: Clinical lymphoma, myeloma & leukemia
Published: November 30, 2020
Showing 1-12 of 22

Last Updated: 09/26/2026